Squamous cell carcinoma | Malignant melanoma | ||
---|---|---|---|
From 30 min to 60 min | |||
P value | 0.1064 | 0.6504 | |
Difference in SUVmaxa | Mean ± SD (Range) | 1.02 ± 0.61 (0.2–2.7) | 1.1 ± 1.7 (−1.4–2) |
RI | Mean ± SD (Range) | 17.6 ± 7.3 (4.7–28.0) | 12.0 ± 15.5 (−17.1–29.9) |
Number of patients with increase | 0 | 3 | |
Number of patients with decrease | 20 | 5 | |
From 60 min to 120 min | |||
P value | 0.1263 | 0.7098 | |
Difference in SUVmax | Mean ± SD (Range) | 0.96 ± 0.56 (0.3–2.6) | 0.91 ± 0.74 (−0.2–2.3) |
RI | Mean ± SD (Range) | 20 ± 6.6 (5.2–29.2) | 13.6 ± 10.9 (−0.02–32.4) |
Number of patients with increase | 0 | 1 | |
Number of patients with decrease | 20 | 7 | |
From 30 min to 120 min | |||
P value | 0.0023 | 0.412 | |
Difference in SUVmax | Mean ± SD (Range) | 1.98 ± 1.02 (0.6–4.7) | 2.03 ± 2.38 (−1.1–7) |
RI | Mean ± SD (Range) | 34.0 ± 8.7 (8.7–46.7) | 22.4 ± 22.3 (−13.4–52.1) |
Number of patients with increase | 0 | 2 | |
Number of patients with decrease | 20 | 6 |